AL
META icon

Aspiriant LLC’s Meta Platforms (Facebook) META Stock Holding History

Aspiriant LLC’s Portfolio META Stock Details META Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.45M Sell
9,533
-1,691
-15% -$1.08M 0.16% 66
2025
Q4 		$7.41M Buy
11,224
+597
+6% +$399K 0.21% 59
2025
Q3 		$7.8M Sell
10,627
-442
-4% -$329K 0.24% 50
2025
Q2 		$8.17M Sell
11,069
-373
-3% -$230K 0.26% 45
2025
Q1 		$6.59M Buy
11,442
+105
+0.9% +$67.7K 0.23% 47
2024
Q4 		$6.64M Sell
11,337
-716
-6% -$420K 0.24% 49
2024
Q3 		$6.9M Buy
12,053
+221
+2% +$114K 0.26% 47
2024
Q2 		$5.97M Sell
11,832
-1,523
-11% -$740K 0.24% 51
2024
Q1 		$6.48M Buy
13,355
+1,633
+14% +$728K 0.27% 49
2023
Q4 		$4.15M Sell
11,722
-396
-3% -$129K 0.19% 59
2023
Q3 		$3.64M Buy
12,118
+450
+4% +$136K 0.19% 61
2023
Q2 		$3.35M Sell
11,668
-33,620
-74% -$8.3M 0.17% 64
2023
Q1 		$9.6M Sell
45,288
-95
-0.2% -$16.2K 0.5% 30
2022
Q4 		$5.46M Sell
45,383
-1,196
-3% -$140K 0.28% 50
2022
Q3 		$6.32M Sell
46,579
-149
-0.3% -$24.1K 0.31% 42
2022
Q2 		$7.54M Buy
46,728
+181
+0.4% +$34.9K 0.36% 36
2022
Q1 		$10.4M Sell
46,547
-426
-0.9% -$106K 0.57% 24
2021
Q4 		$15.8M Sell
46,973
-142
-0.3% -$47.1K 0.84% 20
2021
Q3 		$16M Sell
47,115
-19
-0% -$6.84K 0.94% 19
2021
Q2 		$16.4M Buy
47,134
+21
+0% +$6.74K 0.93% 19
2021
Q1 		$13.9M Sell
47,113
-328
-0.7% -$88.3K 0.89% 20
2020
Q4 		$13M Sell
47,441
-1,865
-4% -$511K 0.88% 20
2020
Q3 		$12.9M Sell
49,306
-266
-0.5% -$68.6K 1.01% 20
2020
Q2 		$11.3M Buy
49,572
+842
+2% +$176K 1.05% 18
2020
Q1 		$8.13M Sell
48,730
-736
-1% -$144K 0.8% 24
2019
Q4 		$10.1M Sell
49,466
-1,354
-3% -$262K 0.94% 22
2019
Q3 		$9.05M Sell
50,820
-2,604
-5% -$495K 0.81% 25
2019
Q2 		$10.3M Sell
53,424
-1,646
-3% -$301K 0.86% 25
2019
Q1 		$9.19M Sell
55,070
-2,113
-4% -$336K 0.75% 26
2018
Q4 		$7.5M Sell
57,183
-3,442
-6% -$499K 0.57% 33
2018
Q3 		$9.96M Sell
60,625
-228
-0.4% -$41.3K 0.85% 27
2018
Q2 		$11.8M Sell
60,853
-539
-0.9% -$97.4K 1.01% 25
2018
Q1 		$9.81M Buy
61,392
+18,316
+43% +$3.29M 0.86% 30
2017
Q4 		$7.6M Sell
43,076
-23,666
-35% -$4.18M 2.23% 16
2017
Q3 		$11.4M Sell
66,742
-206
-0.3% -$34.4K 0.96% 26
2017
Q2 		$10.1M Buy
66,948
+275
+0.4% +$40.9K 0.88% 25
2017
Q1 		$9.47M Buy
66,673
+53,913
+423% +$7.2M 0.81% 30
2016
Q4 		$1.47M Buy
+12,760
New +$1.57M 0.13% 85

Other funds holding META

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Aspiriant LLC's META Position: Q1 2026 in Review

Aspiriant LLC reduced its Meta Platforms (Facebook) (META) stake by 15% in Q1 2026, selling an estimated $1.08M and leaving 9,533 shares worth $5.45M. The position accounts for 0.16% of the portfolio, ranked #66.

Aspiriant LLC first reported a position in META in Q4 2016 and has held it in 38 quarters since. The position peaked at $16.4M in Q2 2021. 5,064 funds tracked by Wall St. Rank hold META as of Q1 2026.

  • Aspiriant LLC held 9,533 shares of Meta Platforms (Facebook) worth $5.45M as of Q1 2026.
  • Aspiriant LLC sold 1,691 Meta Platforms (Facebook) shares in Q1 2026, an estimated $1.08M.
  • Meta Platforms (Facebook) made up 0.16% of Aspiriant LLC's portfolio in Q1 2026, its #66 holding.
  • Aspiriant LLC first reported a position in Meta Platforms (Facebook) in Q4 2016 and has held it in 38 quarters since.
  • Aspiriant LLC's Meta Platforms (Facebook) position peaked at $16.4M in Q2 2021.
  • 5,064 funds tracked by Wall St. Rank held Meta Platforms (Facebook) as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.